Study on Vitamin K Levels in Mature Milk of Chinese Lactating Mothers
Nutrients · 2024
DOI: 10.3390/nu16193351 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2024. Verfasst von Haiyan Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: National Institute for Nutrition and Health, Chinese Center for Disease Control and Prevention, Beijing 100050, China. Hauptthemen laut MEDLINE: Lactation, Milk, Human, Vitamin K. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Health Promotion Foundation Fund Vitamin K2 Public Welfare Specialization, National Financial Projects–Assessment and Application of Nutrients Requirement and Food Environment for Chinese Residents.
Abstract (Originalsprache)
Objectives
This study sought to understand the levels of vitamin K in the mature milk of Chinese lactating mothers, thereby providing a foundation for the development of appropriate intake (AI) of vitamin K for infants aged 0–5 months.
Methods
Five hundred healthy lactating mothers were selected from the mature milk bank established by the Chinese Maternal and Infant Nutrition and Health Cohort by using a simple random sample procedure. Relevant information about lactating mothers and their infants was obtained by a questionnaire survey. Vitamin K1 and vitamin K2 (MK-4 and MK-7) in mature milk were determined by liquid chromatography–tandem mass spectrometry.
Results
The total concentration of vitamin K in mature milk was 4.50 (2.85–6.33) ng/mL. The concentrations of vitamin K1, vitamin K2, MK-4, and MK-7 were 2.81 (1.66–4.39) ng/mL, 1.37 (0.75–2.11) ng/mL, 1.20 (0.58–1.97) ng/mL, and 0.13 (0.08–0.19) ng/mL, respectively. The concentration of vitamin K1 was highest and the concentration of MK-7 was lowest. The concentrations of vitamin K2 and MK-4 in mature milk from the south were significantly higher than those in mature milk from the north. The total vitamin K, vitamin K2, and MK-4 concentrations in mature milk of lactating mothers residing in urban areas were higher than those in rural areas. There was a tendency for the concentration of total vitamin K and vitamin K1 to increase with the mother’s age. Moreover, the concentration of MK-4 in mature milk was highest in summer, followed by spring and winter. The levels of vitamin K1 and MK-4 in mature milk were found to be affected by lactation stage; they were highest at 91–120 days and lowest at 31–60 days.
Conclusions
Based on the concentration of vitamin K in mature milk found in this study, it is recommended that the appropriate intake of VK for Chinese infants aged 0–5 months is 3.49 μg/d (2.18 μg/d for VK1 and 1.06 μg/d for VK2).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Institute for Nutrition and Health, Chinese Center for Disease Control and Prevention, Beijing 100050, China.
- Key Laboratory of Public Nutrition and Health, National Health Commission of the People's Republic of China, Beijing 100050, China.
- Chinese Nutrition Society, Beijing 100050, China.
ORCID-Profile: Huwei Wu, Xuehong Pang, Yichun Hu
Förderung
- China Health Promotion Foundation Fund Vitamin K2 Public Welfare Specialization
- National Financial Projects–Assessment and Application of Nutrients Requirement and Food Environment for Chinese Residents
Zitieren
APA
Wang, H., Yang, Z., Wang, S., Wu, H., Pang, X., Hu, Y., & Yang, X. (2024). Study on Vitamin K Levels in Mature Milk of Chinese Lactating Mothers. Nutrients. https://doi.org/10.3390/nu16193351
Vancouver
Wang H, Yang Z, Wang S, Wu H, Pang X, Hu Y, et al. Study on Vitamin K Levels in Mature Milk of Chinese Lactating Mothers. Nutrients. 2024. doi:10.3390/nu16193351
BibTeX
@article{Wang2024,
author = {Wang, Haiyan and Yang, Zhenyu and Wang, Shuxia and Wu, Huwei and Pang, Xuehong and Hu, Yichun and Yang, Xiaoguang},
title = {Study on Vitamin K Levels in Mature Milk of Chinese Lactating Mothers},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16193351}
}
EUVIMED